What’s your take on the future of companies like BMY and BIIB? It’s been a bad past 12 months for this sector (Hillary against big pharma, approval issues, add in the whole Valeant fiasco to the picture). Is this a value trap?
What’s your take on the future of companies like BMY and BIIB? It’s been a bad past 12 months for this sector (Hillary against big pharma, approval issues, add in the whole Valeant fiasco to the picture). Is this a value trap?